Owners, management and financials
CVR: 39857316
Secondary names: Octarine ApS
Previous names: Octarine Bio IVS
DKK 1,715,333
Gross profit
Net result: DKK -11,501,321
Nicholas Stuart William Milne (10-14,99%), Biosphere ApS (15-19,99%)
6 more
CVR · view owners
Nethaji Janeshawari Gallage, Nicholas Stuart William Milne
Board: Stephan Christgau (chair) and 5 members
CVR · view management
Active
Founded 12 September 2018
CVR · view overview
21 employees
CVR · 2026
Owner registered: Ginkgo Bioworks, Inc.
CVR · 17/12/2025
View the full event history
Octarine Bio ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Octarine Bio IVS. The management consists of Nethaji Janeshawari Gallage and Nicholas Stuart William Milne. The board consists of Stephan Christgau (chair), Akshat Kshetrapal, Alexandre Ouimet-Storrs and Anna Søndergaard. The company's owners include Nicholas Stuart William Milne, Biosphere ApS and UV Fund I K/S. The company has 21 employees (2026). In 2025, the company reported a gross profit of DKK 1,715,333 and a net result of DKK -11,501,321 compared with DKK -22,298,751 the year before. Equity in the 2025 report amounted to DKK 31,907,827.
Source: annual report 2025, Danish Business Authority
Octarine Bio ApS is currently facing significant financial challenges, marked by consistent losses over the past four years, culminating in a profit of -11,501,321 DKK in 2025. While gross profit has shown some fluctuation, peaking at 1,715,333 DKK in 2025, the overall trend indicates a decline in profitability, with equity deteriorating from 6,526,535 DKK in 2021 to 31,907,827 DKK in 2025. The company's equity position has improved, but it remains a concern given the previous negative equity of -44,735,766 DKK in 2024. Operating in the research and experimental development sector, Octarine Bio ApS is still establishing its foothold, facing the dual challenge of maintaining operational viability while seeking to enhance its market position.
AI-generated summary · Generated 15/08/2026
1.2 Selskabets formål er at drive forsknings- og udviklingsvirksomhed indenfor sundhed og kosmetisk pleje og hermed beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 1.7M | -11.5M | 36.7M | 31.9M | 11 | |
| 202401/01/2024 – 31/12/2024 | 388K | -22.3M | 27.9M | -44.7M | 11 | |
| 202301/01/2023 – 31/12/2023 | 1.1M | -19.3M | 34.8M | -22.4M | 9 | |
| 202201/01/2022 – 31/12/2022 | 1.4M | -9.7M | 15.3M | -3.1M | 9 | |
| 202101/01/2021 – 31/12/2021 | 1.7M | -6.4M | 14.7M | 6.5M | 7 | |
| 202001/01/2020 – 31/12/2020 | 917K | -2.4M | 9.3M | -900K | 3 |
Compared to 1.038 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of Octarine Bio ApS is 39857316.
The owners of Octarine Bio ApS include Nicholas Stuart William Milne, Biosphere ApS and UV Fund I K/S.
The management of Octarine Bio ApS consists of Nethaji Janeshawari Gallage and Nicholas Stuart William Milne.
The board of Octarine Bio ApS consists of Stephan Christgau, Akshat Kshetrapal and Alexandre Ouimet-Storrs, with Stephan Christgau as chair.
In 2025, Octarine Bio ApS reported a gross profit of DKK 1,715,333.
Octarine Bio ApS had 21 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 27639353, new email: [email protected], new website: www.octarinebio.com (October 8, 2026).
Contact info changed: new phone: 27639353, new email: [email protected], new website: www.octarinebio.com (October 2, 2026).
As of September 18, 2026, Anna Søndergaard has joined the board of directors of Octarine Bio ApS.
As of September 18, 2026, Jonas Ahm-Lundgren has left the board of directors of Octarine Bio ApS.
Octarine Bio ApS has published its annual report for 2025. Gross profit came to DKK 1,715,333, and the net result was DKK -11,501,321.
Contact info changed: new phone: 27639353, new email: [email protected], new website: www.octarinebio.com (June 10, 2026).
Contact info changed: new phone: 27639353, new email: [email protected], new website: www.octarinebio.com (June 3, 2026).
As of January 1, 2026, Anna Sophie Zimmermann has joined the board of directors of Octarine Bio ApS.
As of January 1, 2026, Anna Sophie Zimmermann has left the board of directors of Octarine Bio ApS.
As of December 17, 2025, Marianne Tochtermann has joined the board of directors of Octarine Bio ApS.
As of December 17, 2025, Helga Claudia Blomgren-Hansen has left the board of directors of Octarine Bio ApS.
As of December 17, 2025, is registered as an owner of Octarine Bio ApS with an ownership share of 5%.
As of July 14, 2025, Jonas Ahm-Lundgren has joined the board of directors of Octarine Bio ApS.
As of July 14, 2025, Nicholas Stuart William Milne is registered as an owner of Octarine Bio ApS with an ownership share of 10%.
As of July 14, 2025, Biosphere ApS is registered as an owner of Octarine Bio ApS with an ownership share of 15%.
As of July 14, 2025, UV Fund I K/S is registered as an owner of Octarine Bio ApS with an ownership share of 5%.
As of July 14, 2025, Danmarks Eksport- og Investeringsfond is registered as an owner of Octarine Bio ApS with an ownership share of 5%.
As of July 14, 2025, The Footprint Fund I K/S is registered as an owner of Octarine Bio ApS with an ownership share of 10%.
As of July 14, 2025, is registered as an owner of Octarine Bio ApS with an ownership share of 5%.
As of July 14, 2025, is registered as an owner of Octarine Bio ApS with an ownership share of 5%.
Octarine Bio ApS has published its annual report for 2024. Gross profit came to DKK 387,863, and the net result was DKK -22,298,751.
Octarine Bio ApS has published its annual report for 2023. Gross profit came to DKK 1,089,445, and the net result was DKK -19,292,175.
As of May 21, 2024, Ri Statsautoriseret Revisionspartnerselskab has been appointed auditor of Octarine Bio ApS.
As of May 20, 2024, Ri Magnoliavej 12 ApS has stepped down as auditor of Octarine Bio ApS.
Octarine Bio ApS has published its annual report for 2022. Gross profit came to DKK 1,378,113, and the net result was DKK -9,671,375.
As of December 31, 2022, Lene Gerlach has left the board of directors of Octarine Bio ApS.
As of December 31, 2022, Christian Brix Tillegreen has left the board of directors of Octarine Bio ApS.
As of August 1, 2022, Nethaji Janeshawari Gallage has joined the board of directors of Octarine Bio ApS.
Octarine Bio ApS has published its annual report for 2021. Gross profit came to DKK 1,681,548, and the net result was DKK -6,418,626.
As of December 15, 2021, Akshat Kshetrapal has joined the board of directors of Octarine Bio ApS.
Octarine Bio ApS has published its annual report for 2020. Gross profit came to DKK 916,667, and the net result was DKK -2,372,514.
As of March 5, 2021, Lene Gerlach has joined the board of directors of Octarine Bio ApS.
On October 14, 2020, the company changed its name from Octarine Bio IVS to Octarine Bio ApS.
As of September 10, 2020, Alexandre Ouimet-Storrs has joined the board of directors of Octarine Bio ApS.
Octarine Bio ApS has published its interim report for the period September 12, 2018 to December 31, 2019.
As of June 30, 2020, Stephan Christgau has joined the board of directors of Octarine Bio ApS.
As of June 30, 2020, Helga Claudia Blomgren-Hansen has joined the board of directors of Octarine Bio ApS.
As of June 30, 2020, Christian Brix Tillegreen has joined the board of directors of Octarine Bio ApS.
As of February 24, 2020, Ri Magnoliavej 12 ApS has been appointed auditor of Octarine Bio ApS.
As of September 12, 2018, Nethaji Janeshawari Gallage is registered as adm. dir. of Octarine Bio ApS.
As of September 12, 2018, Nicholas Stuart William Milne is registered as director of Octarine Bio ApS.
Octarine Bio ApS was founded on September 12, 2018.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Companies in the same industry and area
CVR 45436497
CVR 46543912
CVR 42731323
CVR 17826905
CVR 33687311
